Astrocytic CCAAT/Enhancer Binding Protein δ Regulates Neuronal Viability and Spatial Learning Ability via miR-135a

Yu Yi Chu, Chiung Yuan Ko, Wei Jan Wang, Shao Ming Wang, Po-Wu Gean, Yu-Min Kuo, Ju-Ming Wang

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The progression of Alzheimer’s disease (AD) has been associated with astrocytes-induced neuroinflammation. However, the detailed mechanism of astrocytes associated with learning impairments and neuronal loss in AD is poorly defined. Here, we provide novel evidences that astrocytic miR-135a is critical for neuronal viability and spatial learning ability in vivo. The AppTg/Cebpd−/− mice showed a spatial learning improvement compared with the APPswe/PS1/E9 bigenic (AppTg) mice. miR-135a was found to be a CCAAT/enhancer binding protein δ (CEBPD) responsive miRNA and can repress the transcription of thrombospondin 1 (THBS1) / Thbs1 (mouse) via its 3′-untranslated region (3′UTR). We used different experimental approaches to attenuate the expression of CEBPD/Cebpd (mouse) or miR-135a in astrocytes and found the following results: increase in THBS1/Thbs1 expression, decrease in neuronal apoptosis, and increase in growth of neurites. Importantly, injection of miR-135a antagonist (AM135a) into the brain of AppTg mice was found to prevent neuronal apoptosis and improved the spatial learning ability. Together, our findings demonstrate a critical function for the astrocytic CEBPD, and point to miR-135a antagonist as an attractive therapeutic target for the treatment of Alzheimer’s disease.

Original languageEnglish
Pages (from-to)4173-4188
Number of pages16
JournalMolecular Neurobiology
Volume53
Issue number6
DOIs
Publication statusPublished - 2016 Aug 1

Fingerprint

CCAAT-Enhancer-Binding Proteins
Astrocytes
Alzheimer Disease
Apoptosis
Thrombospondin 1
3' Untranslated Regions
Neurites
MicroRNAs
Learning
Injections
Brain
Therapeutics
Growth
Spatial Navigation
Spatial Learning

All Science Journal Classification (ASJC) codes

  • Neuroscience (miscellaneous)
  • Neurology
  • Cellular and Molecular Neuroscience

Cite this

@article{79012d11fd6a4154a57d68c988077a5d,
title = "Astrocytic CCAAT/Enhancer Binding Protein δ Regulates Neuronal Viability and Spatial Learning Ability via miR-135a",
abstract = "The progression of Alzheimer’s disease (AD) has been associated with astrocytes-induced neuroinflammation. However, the detailed mechanism of astrocytes associated with learning impairments and neuronal loss in AD is poorly defined. Here, we provide novel evidences that astrocytic miR-135a is critical for neuronal viability and spatial learning ability in vivo. The AppTg/Cebpd−/− mice showed a spatial learning improvement compared with the APPswe/PS1/E9 bigenic (AppTg) mice. miR-135a was found to be a CCAAT/enhancer binding protein δ (CEBPD) responsive miRNA and can repress the transcription of thrombospondin 1 (THBS1) / Thbs1 (mouse) via its 3′-untranslated region (3′UTR). We used different experimental approaches to attenuate the expression of CEBPD/Cebpd (mouse) or miR-135a in astrocytes and found the following results: increase in THBS1/Thbs1 expression, decrease in neuronal apoptosis, and increase in growth of neurites. Importantly, injection of miR-135a antagonist (AM135a) into the brain of AppTg mice was found to prevent neuronal apoptosis and improved the spatial learning ability. Together, our findings demonstrate a critical function for the astrocytic CEBPD, and point to miR-135a antagonist as an attractive therapeutic target for the treatment of Alzheimer’s disease.",
author = "Chu, {Yu Yi} and Ko, {Chiung Yuan} and Wang, {Wei Jan} and Wang, {Shao Ming} and Po-Wu Gean and Yu-Min Kuo and Ju-Ming Wang",
year = "2016",
month = "8",
day = "1",
doi = "10.1007/s12035-015-9359-z",
language = "English",
volume = "53",
pages = "4173--4188",
journal = "Molecular Neurobiology",
issn = "0893-7648",
publisher = "Humana Press",
number = "6",

}

Astrocytic CCAAT/Enhancer Binding Protein δ Regulates Neuronal Viability and Spatial Learning Ability via miR-135a. / Chu, Yu Yi; Ko, Chiung Yuan; Wang, Wei Jan; Wang, Shao Ming; Gean, Po-Wu; Kuo, Yu-Min; Wang, Ju-Ming.

In: Molecular Neurobiology, Vol. 53, No. 6, 01.08.2016, p. 4173-4188.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Astrocytic CCAAT/Enhancer Binding Protein δ Regulates Neuronal Viability and Spatial Learning Ability via miR-135a

AU - Chu, Yu Yi

AU - Ko, Chiung Yuan

AU - Wang, Wei Jan

AU - Wang, Shao Ming

AU - Gean, Po-Wu

AU - Kuo, Yu-Min

AU - Wang, Ju-Ming

PY - 2016/8/1

Y1 - 2016/8/1

N2 - The progression of Alzheimer’s disease (AD) has been associated with astrocytes-induced neuroinflammation. However, the detailed mechanism of astrocytes associated with learning impairments and neuronal loss in AD is poorly defined. Here, we provide novel evidences that astrocytic miR-135a is critical for neuronal viability and spatial learning ability in vivo. The AppTg/Cebpd−/− mice showed a spatial learning improvement compared with the APPswe/PS1/E9 bigenic (AppTg) mice. miR-135a was found to be a CCAAT/enhancer binding protein δ (CEBPD) responsive miRNA and can repress the transcription of thrombospondin 1 (THBS1) / Thbs1 (mouse) via its 3′-untranslated region (3′UTR). We used different experimental approaches to attenuate the expression of CEBPD/Cebpd (mouse) or miR-135a in astrocytes and found the following results: increase in THBS1/Thbs1 expression, decrease in neuronal apoptosis, and increase in growth of neurites. Importantly, injection of miR-135a antagonist (AM135a) into the brain of AppTg mice was found to prevent neuronal apoptosis and improved the spatial learning ability. Together, our findings demonstrate a critical function for the astrocytic CEBPD, and point to miR-135a antagonist as an attractive therapeutic target for the treatment of Alzheimer’s disease.

AB - The progression of Alzheimer’s disease (AD) has been associated with astrocytes-induced neuroinflammation. However, the detailed mechanism of astrocytes associated with learning impairments and neuronal loss in AD is poorly defined. Here, we provide novel evidences that astrocytic miR-135a is critical for neuronal viability and spatial learning ability in vivo. The AppTg/Cebpd−/− mice showed a spatial learning improvement compared with the APPswe/PS1/E9 bigenic (AppTg) mice. miR-135a was found to be a CCAAT/enhancer binding protein δ (CEBPD) responsive miRNA and can repress the transcription of thrombospondin 1 (THBS1) / Thbs1 (mouse) via its 3′-untranslated region (3′UTR). We used different experimental approaches to attenuate the expression of CEBPD/Cebpd (mouse) or miR-135a in astrocytes and found the following results: increase in THBS1/Thbs1 expression, decrease in neuronal apoptosis, and increase in growth of neurites. Importantly, injection of miR-135a antagonist (AM135a) into the brain of AppTg mice was found to prevent neuronal apoptosis and improved the spatial learning ability. Together, our findings demonstrate a critical function for the astrocytic CEBPD, and point to miR-135a antagonist as an attractive therapeutic target for the treatment of Alzheimer’s disease.

UR - http://www.scopus.com/inward/record.url?scp=84937908174&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937908174&partnerID=8YFLogxK

U2 - 10.1007/s12035-015-9359-z

DO - 10.1007/s12035-015-9359-z

M3 - Article

VL - 53

SP - 4173

EP - 4188

JO - Molecular Neurobiology

JF - Molecular Neurobiology

SN - 0893-7648

IS - 6

ER -